Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session

Published 21/09/2022, 17:40
Updated 21/09/2022, 18:41
© Reuters.  Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session

© Reuters. Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Stabilis Solutions, Inc. (NASDAQ: SLNG) shares jumped 108% to $10.73 after the company announced it has received authorization from the U.S. Department of Energy to export domestically produced liquefied natural gas to all free trade and non-free trade countries.
  • Evaxion Biotech A/S (NASDAQ: EVAX) gained 47% to $3.0045 as the company reached an important milestone announcing that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01, its personalized cancer therapy.
  • AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) gained 33% to $0.2001.
  • ECMOHO Limited (NASDAQ: MOHO) jumped 31% to $0.1529. ECMOHO announced that it has received delisting notice from the Nasdaq. The company said it has elected to not appeal Nasdaq Listing Qualifications Department's determination.
  • AMTD Digital Inc. (NYSE: HKD) rose 28.3% to $93.00 after dropping 21% on Tuesday.
  • Starry Group Holdings, Inc. (NYSE: STRY) gained 16.6% to $2.11.
  • FREYR Battery (NYSE: FREY) rose 14.5% to $15.05. Morgan Stanley (NYSE:MS) maintained FREYR Battery with an Overweight and raised the price target from $18 to $26.
  • FTAI Infrastructure Inc. (NASDAQ: FIP) gained 11% to $2.8950. Compass Point initiated coverage on FTAI Infrastructure with a Buy rating and announced a price target of $7.
  • Bone Biologics Corporation (NASDAQ: BBLG) jumped 12.3% to $1.18.
  • Semantix, Inc. (NASDAQ: STIX) jumped 11.9% to $2.8758.
  • Apollo Medical Holdings, Inc. (NASDAQ: AMEH) gained 10.5% to $43.26. William Blair initiated coverage on Apollo Medical with an Outperform rating.
  • Fennec Pharmaceuticals Inc. (NASDAQ: FENC) surged 9.9% to $8.39. Fennec Pharmaceuticals announced the FDA approval of PEDMARK.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) gained 9% to $1.0051.
  • AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 8.2% to $1.8299. AgriFORCE recently announced the launch of un(Think) Awakened Flour.
  • Codere Online Luxembourg, S.A. (NASDAQ: CDRO) gained 8% to $2.99.
  • Beyond Meat, Inc. (NASDAQ: NASDAQ:BYND) jumped 7.1% to $17.17. Beyond Meat suspended its Chief Operating Officer, Doug Ramsey, effective immediately.
  • FOXO Technologies Inc. (NYSE: FOXO) rose 7.1% to $2.26 after dropping over 15% on Tuesday.
  • General Mills, Inc. (NYSE: GIS) gained 6.8% to $80.55 after the company reported better-than-expected Q1 EPS results and raised FY23 organic net sales growth guidance.
  • Tutor Perini Corporation (NYSE: TPC) climbed 6.8% to $7.24. Tutor Perini was selected as the design and construction contractor for Phase 1 South of the New American Legion Bridge I-270 Traffic Relief Plan.
  • Ra Medical Systems, Inc. (NYSE: RMED) rose 5.1% to $0.1491 after the company reported results of its special meeting of stockholders and a 1-for-50 reverse stock split.
Losers
  • Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares dipped 43.7% to $0.2025 as the company announced the results from the third planned interim analysis of the Phase 2/3 clinical trial of Tempol in high-risk subjects with early COVID-19 infection. The trial did not achieve its primary endpoint, as measured by comparing the rate of sustained clinical resolution of symptoms of COVID-19 at day 14 of Tempol versus placebo.
  • ShiftPixy, Inc. (NASDAQ: PIXY) dropped 33.1% to $14.41 after the company announced pricing of a $5 million private placement.
  • Sesen Bio, Inc. (NASDAQ: SESN) fell 32.4% to $0.4523. Sesen Bio and privately held Carisma Therapeutics Inc have entered into a merger agreement to combine the companies in an all-stock transaction.
  • SOBR Safe, Inc. (NASDAQ: SOBR) shares fell 30.8% to $2.11. SOBR Safe shares surged 233% on Tuesday following a report suggesting The National Transportation Safety Board is recommending that NHTSA require passive alcohol-detection systems.
  • Amprius Technologies, Inc. (NYSE: AMPX) shares fell 28.6% to $7.85 after jumping 86% on Tuesday.
  • Mobile Global Esports Inc. (NASDAQ: MGAM) fell 25.8% to $2.2694 after the company announced a $5 million private placement priced at-the-market.
  • BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) dropped 22.6% to $4.61. The company on Monday announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) fell 22.4% to $16.13 after jumping around 42% on Tuesday.
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) fell 21.8% to $1.7199 after jumping over 60% on Tuesday.
  • Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) fell 21.4% to $4.80 after declining 13% on Tuesday.
  • Integrated Media Technology Limited (NASDAQ: IMTE) dropped 20.8% to $0.8149.
  • WISeKey International Holding AG (NASDAQ: WKEY) fell 19.9% to $1.77.
  • TRxADE HEALTH, Inc. (NASDAQ: MEDS) dropped 17% to $1.1298. TRxADE HEALTH recently announced Bonum Health, a subsidiary, signed a Telemedicine Services Distribution Deal with Wakefern Food, to deploy telemedicine services throughout ShopRite pharmacy-led locations in New Jersey, New York, Pennsylvania, Connecticut and Maryland.
  • Motorsport Games Inc. (NASDAQ: MSGM) dropped 16.5% to $0.79.
  • Design Therapeutics, Inc. (NASDAQ: DSGN) declined 15% to $16.14.
  • Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) fell 14% to $15.36 as the company announced summary of actions in strategic financial repositioning.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) fell 13.1% to $2.2080. Alaunos Therapeutics highlighted data from TCR-T Library Phase 1/2 trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference.
  • Nexalin Technology, Inc. (NASDAQ: NXL) fell 12.5% to $1.40.
  • Pliant Therapeutics, Inc. (NASDAQ: PLRX) dropped 12% to $19.90.
  • PureTech Health plc (NASDAQ: PRTC) declined 11.6% to $25.80.
  • Heliogen, Inc. (NYSE: HLGN) fell 11.1% to $1.7150.
  • iRhythm Technologies, Inc. (NASDAQ: IRTC) dropped 10.4% to $139.25. iRhythm Technologie reaffirmed its previously provided financial guidance for 2022, according to Reuters.
  • Veru Inc. (NASDAQ: VERU) fell 10.2% to $10.65.
  • XPeng Inc. (NYSE: XPEV) dropped 9.7% to $14.39.
  • Aurora Cannabis Inc. (NASDAQ: ACB) fell 7.2% to $1.2993. Aurora Cannabis reported its financial and operational results for the fourth quarter and fiscal year ending June 30, 2022, on Tuesday, revealing a net revenue of $50.2 million compared to the previous quarter's total cannabis net revenue of $50.4 million.
  • Zovio Inc (NASDAQ: ZVO) fell 6.1% to $0.1834.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.